# Treatment of COVID-19 Post-acute Cognitive Impairment Sequelae With tDCS

> **NCT05389592** · NA · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 60 (actual)

## Conditions studied

- Cognitive Impairment
- Post-Acute Sequelae of SARS-CoV-2 Infection
- COVID-19

## Interventions

- **PROCEDURE:** Active tDCS and cognitive training
- **PROCEDURE:** Sham tDCS and cognitive training

## Key facts

- **NCT ID:** NCT05389592
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-30
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05389592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05389592, "Treatment of COVID-19 Post-acute Cognitive Impairment Sequelae With tDCS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05389592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*